Asthma
Conference Coverage
Tezepelumab reduces exacerbations in persistent, treatment-resistant asthma
New monoclonal antibody targets an inflammatory cytokine known to be promoted in asthmatic airways.
From the Journals
Add-on azithromycin cuts asthma exacerbations
An add-on therapy reduced patients’ asthma exacerbation incidents.
From the Journals
Children with HIV benefit from double dose of PCV13 vaccine
At-risk children may need new PCV13 vaccine regimens.
From the Journals
Childhood asthma linked to high LV mass later
A history of childhood asthma correlates with high left ventricular mass, a prominent indicator of cardiac damage, in asymptomatic healthy young...
Conference Coverage
Biologic may reduce glucocorticoid use
WASHINGTON – Patients taking benralizumab show evidence of significantly reduced glucocorticoid use while maintaining asthma control.
From the Journals
Imatinib cuts mast cells in severe asthma
In a trial, imatinib decreased airway mast-cell counts and airway hyperresponsiveness in adults with asthma, who were not responding well to...
From the Journals
Mepolizumab proves effective for eosinophilic granulomatosis with polyangiitis
The anti–interleukin-5 monoclonal antibody beat placebo for total accrued weeks of remission and remission after 36 and 48 weeks of treatment.
Conference Coverage
Many patients’ severe asthma remains uncontrolled
ATLANTA – More than one-third of patients with severe asthma have disease that remains uncontrolled a year after they come in for treatment.
Conference Coverage
Omalizumab may help chronic rhinosinusitis symptoms
An asthma drug helped patients with severe and recalcitrant chronic rhinosinusitis.
Conference Coverage
A history of asthma exacerbations predicts future exacerbations
Flag patients at high risk of asthma exacerbations.
Conference Coverage
Failed ear tubes and antibiotics? Think eosinophilic otitis media
Treating adults with severe, chronic ear pain? Consider a recently described disease entity called eosinophilic otitis media.